|
2025-03-18 |
2025-03-17 |
B
Purchase
|
Sohn Catherine A.
Non-Executive Director
|
1,000
+inf%
5.78
USD 5,785
|
1,000
+inf%
|
5.78
|
USD 5,785
|
|
|
2025-03-14 |
2025-03-13 |
B
Purchase
|
WEAVER GREGORY L
Chief Financial Officer
Officer
|
10,000
+inf%
5.20
USD 51,996
|
10,000
+inf%
|
5.20
|
USD 51,996
|
|
|
2024-08-20 |
2024-08-19 |
S
Sale
|
Drutz David
Non-Executive Director
|
8,184
-12.8%
6.88
USD 56,306
|
8,184
-12.8%
|
6.88
|
USD 56,306
|
|
|
2024-08-20 |
2024-08-19 |
S
Sale
|
Drutz David
Non-Executive Director
|
7,827
-15.7%
6.93
USD 54,241
|
7,827
-15.7%
|
6.93
|
USD 54,241
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Drutz David
Non-Executive Director
|
300
+1.0%
2.88
USD 863
|
300
+1.0%
|
2.88
|
USD 863
|
|
|
2023-03-24 |
2023-03-24 |
B
Purchase
|
Eisenstadt Richard I
Chief Financial Officer
Officer
|
10,000
+83.3%
4.31
USD 43,140
|
10,000
+83.3%
|
4.31
|
USD 43,140
|
|
|
2023-03-27 |
2023-03-23 |
B
Purchase
|
Drutz David
Non-Executive Director
|
9,000
+43.9%
4.27
USD 38,430
|
9,000
+43.9%
|
4.27
|
USD 38,430
|
|
|
2023-03-23 |
2023-03-23 |
B
Purchase
|
Harris Matthew Scott
Chief Medical Officer
Officer
|
10,000
+42.9%
4.22
USD 42,200
|
10,000
+42.9%
|
4.22
|
USD 42,200
|
|
|
2022-12-22 |
2022-12-22 |
PS
Planned sale
|
Pisano Wayne
Non-Executive Director
|
20,000
-70.2%
15.01
USD 300,268
|
20,000
-70.2%
|
15.01
|
USD 300,268
|
|
|
2022-09-01 |
2022-08-31 |
PS
Planned sale
|
Garg Vipin K
President and CEO
Executive Director
|
20,000
-7.8%
20.02
USD 400,322
|
20,000
-7.8%
|
20.02
|
USD 400,322
|
|
|
2023-07-06 |
2022-08-12 |
S
Sale
|
GILL JOHN
Non-Executive Director
|
2,714
-49.5%
15.00
USD 40,710
|
2,714
-49.5%
|
15.00
|
USD 40,710
|
|
|
2022-08-12 |
2022-08-12 |
PS
Planned sale
|
Garg Vipin K
President and CEO
Executive Director
|
15,000
-5.5%
15.06
USD 225,890
|
15,000
-5.5%
|
15.06
|
USD 225,890
|
|
|
2022-07-05 |
2022-07-05 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
10,182
-55.1%
12.00
USD 122,184
|
10,182
-55.1%
|
12.00
|
USD 122,184
|
|
|
2022-07-05 |
2022-07-01 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
26,982
-60.4%
12.00
USD 323,784
|
26,982
-60.4%
|
12.00
|
USD 323,784
|
|
|
2022-06-28 |
2022-06-27 |
PS
Planned sale
|
Roberts M Scot
Chief Scientific Officer
Officer
|
37,352
-67.8%
12.00
USD 448,254
|
37,352
-67.8%
|
12.00
|
USD 448,254
|
|
|
2022-06-28 |
2022-06-27 |
PS
Planned sale
|
Jorkasky Diane
Non-Executive Director
|
17,610
-100.0%
11.75
USD 206,944
|
17,610
-100.0%
|
11.75
|
USD 206,944
|
|
|
2022-06-16 |
2022-06-15 |
B
Purchase
|
Drutz David
Non-Executive Director
|
1,000
+5.3%
8.00
USD 8,000
|
1,000
+5.3%
|
8.00
|
USD 8,000
|
|
|
2022-05-25 |
2022-05-24 |
B
Purchase
|
Drutz David
Non-Executive Director
|
1,200
+6.7%
4.50
USD 5,400
|
1,200
+6.7%
|
4.50
|
USD 5,400
|
|
|
2022-03-02 |
2022-02-28 |
PS
Planned sale
|
Harris Matthew Scott
Chief Medical Officer
Officer
|
30,000
-72.2%
7.52
USD 225,600
|
30,000
-72.2%
|
7.52
|
USD 225,600
|
|
|
2021-03-01 |
2021-03-01 |
PS
Planned sale
|
Hodges Philip
Non-Executive Director
|
6,000
-40.7%
16.08
USD 96,480
|
6,000
-40.7%
|
16.08
|
USD 96,480
|
|
